Targeting YAP in malignant pleural mesothelioma

Malignant mesothelioma is an aggressive cancer that is resistant to current therapy. The poor prognosis of mesothelioma has been associated with elevated Yes‐associated protein (YAP) activity. In this study, we evaluated the effect of targeting YAP in mesothelioma. First, we comprehensively studied...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Cell Mol Med
Egile Nagusiak: Zhang, Wen‐Qian, Dai, Yu‐Yuan, Hsu, Ping‐Chih, Wang, Hui, Cheng, Li, Yang, Yi‐Lin, Wang, Yu‐Cheng, Xu, Zhi‐Dong, Liu, Shu, Chan, Geraldine, Hu, Bin, Li, Hui, Jablons, David M., You, Liang
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2017
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5661117/
https://ncbi.nlm.nih.gov/pubmed/28470935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13182
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak